DeCuzzi Nicholaus L, Oberbauer Daniel, Chmiel Kenneth J, Pargett Michael, Ferguson Justa M, Murphy Devan, Hardy Marion, Ram Abhineet, Zeki Amir A, Albeck John G
Department of Molecular and Cellular Biology.
Division of Pulmonary, Critical Care, and Sleep Medicine, Lung Center, Department of Internal Medicine, School of Medicine, and.
Am J Respir Cell Mol Biol. 2025 May;72(5):520-532. doi: 10.1165/rcmb.2024-0256OC.
Spatially coordinated extracellular signal-regulated kinase (ERK) signaling events (SPREADs) transmit radially from a central point to adjacent cells via secreted ligands for EGFR (epidermal growth factor receptor) and other receptors. SPREADs maintain homeostasis in nonpulmonary epithelia, but it is unknown whether they play a role in the airway epithelium or are dysregulated in inflammatory disease. To address these questions, we measured SPREAD activity with live-cell ERK biosensors in human bronchial epithelial cell lines (HBE1 and 16HBE) and primary human bronchial epithelial cells, in both submerged and biphasic air-liquid interface culture conditions (i.e., differentiated cells). Airway epithelial cells were exposed to proinflammatory cytokines relevant to asthma and chronic obstructive pulmonary disease. Type 1 proinflammatory cytokines significantly increased the frequency of SPREADs, which coincided with epithelial barrier breakdown in differentiated primary human bronchial epithelial cells. Furthermore, SPREADs correlated with IL-6 peptide secretion and the appearance of localized clusters of phospho-STAT3 immunofluorescence. To probe the mechanism of SPREADs, cells were cotreated with pharmacological treatments (gefitinib, tocilizumab, hydrocortisone) or metabolic modulators (insulin, 2-deoxyglucose). Hydrocortisone, inhibitors of receptor signaling, and suppression of metabolic function decreased SPREAD occurrence, implying that proinflammatory cytokines and glucose metabolism modulate SPREADs in human airway epithelial cells via secreted EGFR and IL6R ligands. We conclude that spatiotemporal ERK signaling plays a role in barrier homeostasis and dysfunction during inflammation of the airway epithelium. This novel signaling mechanism could be exploited clinically to supplement corticosteroid treatment for asthma and chronic obstructive pulmonary disease.
空间协调的细胞外信号调节激酶(ERK)信号转导事件(SPREADs)通过表皮生长因子受体(EGFR)和其他受体的分泌配体从中心点径向传递至相邻细胞。SPREADs维持非肺上皮细胞的稳态,但它们是否在气道上皮中发挥作用或在炎症性疾病中失调尚不清楚。为了解决这些问题,我们在人支气管上皮细胞系(HBE1和16HBE)以及原代人支气管上皮细胞中,在浸没和双相气液界面培养条件下(即分化细胞),使用活细胞ERK生物传感器测量了SPREAD活性。气道上皮细胞暴露于与哮喘和慢性阻塞性肺疾病相关的促炎细胞因子。1型促炎细胞因子显著增加了SPREADs的频率,这与分化的原代人支气管上皮细胞中的上皮屏障破坏相吻合。此外,SPREADs与IL-6肽分泌以及磷酸化STAT3免疫荧光局部簇的出现相关。为了探究SPREADs的机制,细胞用药物治疗(吉非替尼、托珠单抗、氢化可的松)或代谢调节剂(胰岛素、2-脱氧葡萄糖)进行联合处理。氢化可的松、受体信号抑制剂和代谢功能抑制降低了SPREADs的发生,这意味着促炎细胞因子和葡萄糖代谢通过分泌的EGFR和IL6R配体调节人气道上皮细胞中的SPREADs。我们得出结论,时空ERK信号在气道上皮炎症期间的屏障稳态和功能障碍中发挥作用。这种新的信号机制可在临床上用于补充哮喘和慢性阻塞性肺疾病的皮质类固醇治疗。